Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing

Dr. Joel Warsh

👤 Person
798 total appearances

Appearances Over Time

Podcast Appearances

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

I want to talk, because I think that's super important, because it's really, really important to be very specific, because I've even heard RFK say this incorrectly. I know he knows, but he doesn't always say it very specifically, and it's really important. So every single vaccine, before it hits the market, it's studied against a placebo. The thing is, a lot of those placebos are not inert.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

That's right. And that's the key thing. Well, right, right. It's like, well, you're giving it time. But they say the word placebo, so they can say, no, no, it was placebo-controlled, studied, and they were, but it was studied against another vaccine. or an earlier version of the vaccine.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

That's right. And that's the key thing. Well, right, right. It's like, well, you're giving it time. But they say the word placebo, so they can say, no, no, it was placebo-controlled, studied, and they were, but it was studied against another vaccine. or an earlier version of the vaccine.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

That's right. And that's the key thing. Well, right, right. It's like, well, you're giving it time. But they say the word placebo, so they can say, no, no, it was placebo-controlled, studied, and they were, but it was studied against another vaccine. or an earlier version of the vaccine.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

Basically, all the vaccines on the market that are the children vaccines were never studied against an inert placebo. Like a water, like saline. They never studied against saline. And so when somebody says they weren't studied against a placebo, then another person listening who's very pro-vaccines Oh, no, no, they were. What are you talking about? They have all this pre-licensure testing.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

Basically, all the vaccines on the market that are the children vaccines were never studied against an inert placebo. Like a water, like saline. They never studied against saline. And so when somebody says they weren't studied against a placebo, then another person listening who's very pro-vaccines Oh, no, no, they were. What are you talking about? They have all this pre-licensure testing.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

Basically, all the vaccines on the market that are the children vaccines were never studied against an inert placebo. Like a water, like saline. They never studied against saline. And so when somebody says they weren't studied against a placebo, then another person listening who's very pro-vaccines Oh, no, no, they were. What are you talking about? They have all this pre-licensure testing.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

But it's very specific. They rigged the deck. They studied against another vaccine. They study it in the setting of doing other vaccines. Most studies are looking at one vaccine versus another vaccine in the setting of getting all the rest of your vaccines. So you're not studying vaccinated versus unvaccinated kids. So you don't have a true baseline of safety.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

But it's very specific. They rigged the deck. They studied against another vaccine. They study it in the setting of doing other vaccines. Most studies are looking at one vaccine versus another vaccine in the setting of getting all the rest of your vaccines. So you're not studying vaccinated versus unvaccinated kids. So you don't have a true baseline of safety.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

But it's very specific. They rigged the deck. They studied against another vaccine. They study it in the setting of doing other vaccines. Most studies are looking at one vaccine versus another vaccine in the setting of getting all the rest of your vaccines. So you're not studying vaccinated versus unvaccinated kids. So you don't have a true baseline of safety.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

And there's a huge difference in a vaccine study between saying the old DTP versus the new DTP. is safe versus DTP is safe versus nothing. And that doesn't mean that there's a safety issue, but they're all studied in that way. Right. And if you go back through with history.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

And there's a huge difference in a vaccine study between saying the old DTP versus the new DTP. is safe versus DTP is safe versus nothing. And that doesn't mean that there's a safety issue, but they're all studied in that way. Right. And if you go back through with history.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

And there's a huge difference in a vaccine study between saying the old DTP versus the new DTP. is safe versus DTP is safe versus nothing. And that doesn't mean that there's a safety issue, but they're all studied in that way. Right. And if you go back through with history.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

It is a lack of integrity to a degree. So I think we're in this weird place now.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

It is a lack of integrity to a degree. So I think we're in this weird place now.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

It is a lack of integrity to a degree. So I think we're in this weird place now.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

They certainly want to minimize their chance for having a problem. They rigged the deck in a sense, because if you're doing a blinded study, unless you're lying, then you don't really know who's getting what. So the best way to rig the deck is to put it against something that's going to have a similar profile, and then you minimize your chance to have a problem.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

They certainly want to minimize their chance for having a problem. They rigged the deck in a sense, because if you're doing a blinded study, unless you're lying, then you don't really know who's getting what. So the best way to rig the deck is to put it against something that's going to have a similar profile, and then you minimize your chance to have a problem.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

They certainly want to minimize their chance for having a problem. They rigged the deck in a sense, because if you're doing a blinded study, unless you're lying, then you don't really know who's getting what. So the best way to rig the deck is to put it against something that's going to have a similar profile, and then you minimize your chance to have a problem.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About — with Dr. Joel Warsh

Exactly. And then when they both have the same profile of issues, so let's say you test Advil versus Aleve.